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Edited by Lukas HuberAbstract Circadian entrainment involves photic stimulation of
the suprachiasmatic molecular oscillator, including activation
of the ERK/MAP kinase, which is phosphorylated endogenously
during the day and in response to light during the night. We
aimed to disrupt the diurnal cycle of ERK phosphorylation by
in vivo transfection of a constitutively active form of MEK, a
MAPK kinase. This procedure did not aﬀect normal circadian
parameters, but completely inhibited light-induced phase ad-
vances. Therefore, circadian regulation of the ERK pathway is
not essential for the normal mechanism of the biological clock,
but it is fundamental as an interface with environmental entrain-
ment by light.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Mammalian circadian rhythms are orchestrated by a central
suprachiasmatic nuclei pacemaker (SCN) [1,2]. The molecular
core of this clock consists of a transcription/translation feed-
back loop which comprises positive and negative cycling ele-
ments [3,4]. The clock is reset by external factors, in
particular by short light pulses which induce phase delays dur-
ing the early night or phase advances late at night [5]. Photic
signals reach the SCN through a direct retinohypothalamic
tract (RHT) and a glutamatergic/calcium-depending signaling
pathway. In response to a glutamatergic signal from the retina
[6,7], immediate-early genes [8,9] and clock genes [10–12] are
expressed in the SCN. Circadian photic signaling involves
the mitogen-activated protein kinase (MAPK) family [13–16],
activated through a pathway of phosphorylated kinases such
as MEK [17]. Among the members of the MAPK family, phos-
pho-ERK1/2 is rhythmic in the SCN and is controlled by light
[14–16]. Since this pathway plays an important role in entrain-
ment and could also be involved in rhythm generation, we
sought to eliminate variations in MAPK phosphorylation by
the constitutive activation of MEK in the SCN, in order to*Corresponding author. Fax: +54 11 4365 7132.
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doi:10.1016/j.febslet.2006.11.019analyze its eﬀect on the circadian pattern of locomotor activity
and circadian responses to light.2. Materials and methods
Male adult Syrian hamsters (Mesocricetus auratus) were housed un-
der a 14–10 h light:dark cycle with food and water ad libitum. All ani-
mals were housed individually in polypropylene cages equipped with a
17-cm diameter wheel; locomotion was monitored in 6-min bins using
Dataquest III (Minimitter Co., OR). After a week of exposure to a 14–
10 h LD cycle, animals were transferred to constant conditions (DD,
dim red illumination; <1 lux). Activity onset is deﬁned as circadian
time 12 (CT12). After at least 10 days in DD, hamsters were transfec-
ted with pEGFP or pMEKee. Light pulses (5 min, 600 lux) were ap-
plied at late subjective-night (CT 18) 48 h and 20 days after
transfection. Phase shifts of circadian rhythms were calculated as the
diﬀerence between two eye-ﬁtted lines through consecutive activity on-
set before and after the day of a stimulus (day 0), discarding days 1–4.
To test transfection eﬃciency we used the pEGFP-C1 (Kanr) mam-
malian expression vectors (CLONTECH) as a reporter, carrying
EGFP (enhanced green ﬂuorescent protein) complete coding sequences.
To induce sustained activation of ERK we used pCDNA (Ampr) mam-
malian expression vectors carrying MEK1 (pMEKee) or RASV7
(pRASV7) complete coding sequences [18]. In all cases, expression
was driven by a Cytomegalovirus (CMV) promoter and a Simianvirus
(SV40) polyadenylation signal (Fig. 1A).
Plasmids was ampliﬁed in Escherichia coli (top10, Invitrogen) in LB
liquid medium with kanamicine or ampicillin (Gibco), puriﬁed in Qia-
gen anionic exchange columns, resuspended in deionized MilliQ-grade
water and quantiﬁed by their optical density at 260 nm (SmartPec
3000, BioRAD).
We ﬁrst assayed naked DNA transfections (5, 10, 20 or 40 lg/2ll).
Five or ten micrograms of the pEGFP-C1 did not induce ﬂuorescent
signals, while 20 and 40 lg yielded extremely low levels of expression.
Therefore, in vivo plasmid delivery was optimized by using a cationic
polimer (PEI; polyethylenimine, Aldrich Chemical Co.). We chose a
branched PEI of 25 kD and PEI/DNA complex at six charge equiva-
lents (ratio 6) in 5% glucose.
In transfection experiments plasmids (pEGFP, pMEKee or
pRASV7) were administered i.c.v. by 22-ga. stainless steel cannulae,
placed under pentobarbital anaesthesia (80 mg/kg) between the sup-
rachiasmatic nuclei (AP +0.6 mm; ML 0.0 mm from bregma; DV
8.2 mm from dura; tooth bar 2.0 mm). Injection contained 2 ll of
DNA/PEI mix (5 lg of plasmid, 4.3 ng/ll of polyethylenimine, 5% glu-
cose; ﬁnal ratio = 6) and administration ﬂux was 0.4 ll/min. Final lev-
els of PEI administered in CNS tissue was 0.1 lmoles.
24 h, 72 h, 7 days or 14 days after pEGFP transfection, animals were
perfused (4% paraformaldehyde/0.1 M PB). Brains were removed and
transferred into 30% sucrose; 40 lm coronal sections were cut and
visualized with a ﬂuorescent microscope (Nikon Alphaphot-2 YS2).
For p-ERK assays, animals were sacriﬁced 48 h after pEGFP and
pMEKee i.c.v. administration, during late subjective-night (CT 18).
SCN were punched out and homogenized in Tris–HCl buﬀer 50 mM
(pH 7.4), with 0.32 M sucrose, 1 mM EGTA, 1 mM EDTA, 50 mM
NaF, a protease inhibitor cocktail (AEBSF, E-64, bestatin, aprotinin
and leupeptin), 2 mM sodium ortovanadate and 10 lM okadaic acidblished by Elsevier B.V. All rights reserved.
Fig. 1. GFP expression in transfected suprachiasmatic nuclei (SCN).
(A) Constructs used for in vivo transfection. CMV: citomegalovirus
promotor; SV40 pA: Simianvirus polyadenylation site; EGFP:
enhanced green ﬂuorescent protein; MEKee: constitutive active
mutant MEK. (B) Coronal sections from hamsters transfected
in vivo with pEGFP and sacriﬁced 24 h, 72 h, 7 days or 14 days after
plasmid delivery. GFP expression showed high levels 72 h post-
transfection. Green ﬂuorescence decayed to undetectable levels 14 days
after transfection. OC: optic chiasm; 3V: third ventricle. Broken lines
represent the approximate boundaries of the SCN.
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and transferred to Hybond nitrocellulose membranes from Amersham
Bioscience) were incubated for 12 h at 4 C with anti-diphospho-
ERK1/2 antibodies (Santa Cruz, 1:500). Blots were stripped and rein-
cubated 12 h at 4 C with polyclonal goat antibody anti-ERK1/2 (San-
ta Cruz, 1:1000). Immunoreactivity was assessed using a secondary
antibody coupled to HRP, visualised with the ECL kit (Amersham)
and quantiﬁed through digital analysis of densitometry of immunore-
active bands.3. Results
We tested the eﬃciency and kinetics of in vivo transfection
using EGFP as a gene reporter, located in an expression vector
with the same characteristics than the one used for pMEKee
and pRASV7 (Fig. 1A). Maximal values of GFP expression
were found 72 h post-transfection. Two weeks after transfec-
tion, GFP levels were undetectable (Fig. 1B). Constitutive acti-
vation is permanent as long as the plasmid is expressed;
however, this expression is indeed time-limited, as we demon-
strated by looking at GFP at various times following transfec-tion (shown in Fig. 1B). We assumed that the kinetics of the
MEKee vector are similar to the GFP-carrying vector, so that
20 days after transfection there should be no expression left.
In order to assess the implication of the ERK-MAPK path-
way in circadian regulation we aimed to eliminate the endoge-
nous variation of SCN ERK phosphorylation by expressing a
constitutive active form of ERK-MAPK kinase (mutant
MEK1) through an eukaryotic expression plasmid (pMEKee).
An expression plasmid containing pEGFP did not aﬀect
light-induced phase advances of locomotor activity rhythms
(Fig. 2A, B). As shown in Fig. 2C, pMEKee in vivo transfec-
tion did not aﬀect the generation of circadian rhythms of ham-
ster wheel-running activity, but completely inhibited light-
induced phase advances when light pulses were applied at
CT18, 48 h after pMEKee transfection (Fig. 2D). This eﬀect
was reversible, since normal phase shifts were found when light
pulses were administered 20 days after transfection.
We analyzed SCN p-ERK levels by Western blotting at CT
18 (a time along the circadian cycle when levels are signiﬁ-
cantly lower than during the subjective day) 48 h after pME-
Kee transfection. As shown in Fig. 3A, p-ERK-MAPK levels
at CT18 were signiﬁcantly higher in animals transfected with
pMEKee as compared to untransfected and pEGFP-transfec-
ted tissue (Fig. 3A, C). p-ERK-MAPK levels in pMEKee-
transfected tissue attained values comparable to diurnal levels
in control animals. The total amount of ERK was equal
among the diﬀerent samples under analysis (Fig. 3B).4. Discussion
Recent reports indicate that three well-known MAPKs
(ERK, JNK and p38) are rhythmic and light-responsive in
the SCN [13–15,19], and could integrate entrainment path-
ways. Other than light, ERK is modulated in the SCN by dark-
ness and a variety of extracellular signals such as NGF,
PACAP, GRP or EGF [14,20–22] and controls downstream
pathways [23,24]. Here, we show that transient disruption of
the normal temporal pattern of this pathway in the hamster
SCN results in a signiﬁcant and reversible inhibition of light-
induced phase advances of circadian rhythms.
In our knowledge, this is the ﬁrst study of circadian behavior
which uses in vivo transfection by means of plasmid expres-
sion. Other transfection methods have been used with diverse
purposes in the SCN, such as adenoviral-mediated transfection
[25,26] or antisense DNA infusion [27]. In the present study,
constitutive expression of MAPK kinase was driven through
a plasmid construct transfected into the bottom of the third
ventricle. We initially tested diﬀerent transfection protocols
by using a plasmid vector (pEGFP) carrying an enhanced
green ﬂuorescent protein as reporter, as well as the cationic
polymer polyethylenimine (PEI) as an adjuvant, obtaining high
levels of transient GFP expression in the ventrolateral SCN for
at least 72 h. When we transfected pMEKee (a constitutive
mutant of MAPK kinase), the hypotheses were that, by keep-
ing ERK constitutively activated, (i) circadian rhythms would
be disrupted if this oscillation was necessary for the molecular
clock mechanism, and/or (ii) circadian responses to light would
be inhibited if high levels of p-ERK were attained during the
night, in contrast with the control nocturnal low activity.
Our data are in favour of the second hypothesis, since consti-
tutive MAPK kinase activation completely blocked the re-
Fig. 2. Eﬀects of MEKee on locomotor activity rhythms of hamsters. A, B and C shown representative double-plotted actograms of hamster
running-wheel circadian rhythms. Each horizontal line represents the activity record for 48-h periods, and successive days are plotted below one
another. Circadian time 12 (CT12) is deﬁned as the start of the activity period: (A) application of light pulse (5 min, 600 lux) to control animals at CT
18; (B) transfection of pEGFP and application of light pulse at CT 18, 48 h after transfection protocol; (C) transfection of pMEKee and application
of light pulse at CT 18, 48 h and 20 days after transfection protocol; (D) summary of light-induced phase shifts of locomotor activity. LP: light pulse;
T: transfection. (ANOVA: P < 0.0001. **: P < 0.001 vs. control; *: P < 0.01 vs. control; #: P < 0.001 vs. pMEKee 48 h, Tukey’s test).
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Fig. 3. MEKee-induced activation of ERK1/2-MAPK at CT 18 in
hamster SCN. (A) p-ERK1/2 levels; (B) total ERK levels; (C)
densitometric analysis of Western blots (expressed as means ± S.E.M.
of four independent experiments and relative to CT18 control levels).
*: P < 0.01 CT 18 pMEKee vs. CT 18; **: P < 0.001 CT 6 vs. CT 18
(ANOVA, Tukey’s test).
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mal parameters of wheel-running circadian rhythms. In vivo
transfection with a vector (pRASV7) that induces constitutive
activation of ras had the same result, i.e., a complete inhibition
of light-dependent phase advances (supplementary ﬁgure 1).
MEKee transfection also increased p-ERK at CT 18, reach-
ing levels similar to those found during the subjective day, indi-
cating that the diurnal variation of ERK phosphorylation had
been completely inhibited, in comparison with normal varia-
tions in untransfected or pEGFP-transfected animals. More-
over, total ERK levels did not change throughout the day,
indicating post-transcriptional regulation of kinase activity.
Pharmacological inhibition of the MEK/ERK pathway
attenuates phase advances of wheel-running behaviour in ham-
sters [19]. Our results indicate that ERK needs to be in its
dephosphorylated form in order for light to induce phase ad-
vances at CT18, since a sustained activation inhibited photic
stimulation.
Our delivery system elicited the reporter expression of GFP
mainly in the shell and retinorecipient area of the SCN. In mice
and hamsters, ERK exhibits a sustained activation in the ros-
tral, medial and caudal portions of the shell and a nocturnal,
retino-dependent increase in the caudal region of the core area
of the SCN [28]. It is possible that a ventral, retinorecipient
activation of ERK is needed in order to transduce photic sig-
nals.
MAPK levels are regulated both by phosphorylation
through MEK and by dephosphorylation by MAPK phospha-
tases (MKP) [17,29]. Our high levels of nocturnal p-ERK
6668 E.C. Hainich et al. / FEBS Letters 580 (2006) 6665–6668could also aﬀect MKP activity, thus disrupting the normal
transient cycle of kinase progression. Indeed, MKP expression
has been reported in the SCN [30], and we have found that
MKP1/2 activity is also induced by light pulses at CT 18,
but not at CT 6, in the SCN (Pizzio et al., unpublished).
In summary, our present results strongly support a role for
the ERK-MAPK pathway in photic circadian entrainment.
Since MAPK regulation is involved in diverse transductional
cascades, this pathway might serve as an integrator of aﬀerent
signalling into the circadian clock.
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